Within the framework of the 78th Congress of the American Society for Reproductive Medicine (ASRM) The study of the embryo after its devitrification prior to transfer by means of an…
Human reproduction is notoriously inefficient. This has led to efforts to improve this efficiency during IVF with extended embryo culture, traditional morphology grading, and more recently with the use of…
Within the framework of the 38th Congress of the European Society of Human Reproduction and Embryology (ESHRE) Embryo and endometrium are two fundamental players in the gestation process. IVIRMA doctors…
IVIRMA ) innovation is one of the four pillars of IVIRMA Global, the world’s largest company exclusively devoted to human Assisted Reproduction Technology (ART). A reality that began to take shape in 2017, IVIRMA ) innovation strives to lead scientific research and technology development in reproductive medicine and ART, with the ultimate aim of improving patient care.
To redefine the present and shape the future, IVIRMA brings together innovative investigators from the Old and the New Continent, promotes refining research techniques and encourages sharing knowledge.
Scientific innovation, technological progress, educational commitment, and clinical expertise… with one common goal: Excellence in Patient Care.
